FDA Approves 2 gMG Treatments, AR1001 Slows Decline in Monotherapy Group of POLARIS-AD Trial, Benjamin Greenberg's, MD, MHS, Insights From the 2026 RNDS

Author profile image Aggregator
0 comments
Neurology News Network for the week ending November 21st, 2026. [WATCH TIME: 6 minutes]

Source: NeurologyLive Published 21 Nov 2026 Imported 21 Nov 2026 Relevancy: Not reviewed

Read the article